Centrefy

Holistic Solution for Improved Medication Adherence and Treatment Outcomes

Health Tech & Life Sciences
Non Active, Dec 2025 ceased to operate
Follow

Company Overview

Snapshot

Founded in October 2019 by Nati Nachmany, Centrefy operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its core technology.

Business overview

Centrefy is a Health Tech & Life Sciences company developing a holistic solution to enhance quality of care through innovative technology. Its core product, Victor, is a proactive health companion that utilizes AI and machine vision to assist enterprises in achieving health objectives and addressing customer requirements. Victor's platform monitors patient progress, predicts treatment outcomes, and supports the entire drug consumption cycle by collecting and analyzing data and digital biomarkers. The technology can also predict health deterioration by identifying patterns related to hospitalization and medication non-adherence, integrating with IoT devices to improve patient adherence and enable in-depth data analysis for precision medicine. Centrefy leverages data science, digital medicine, informatics, and artificial intelligence to convert valuable data into actionable insights, primarily serving hospitals, pharma companies, and home care providers, with a focus on patients and seniors.

Log in to access full profile

Company Intelligence Q&A

What is Centrefy's primary focus?
Centrefy is focused on developing a holistic solution for improved medication adherence and treatment outcomes, leveraging AI and machine vision technologies.
Who founded Centrefy?
Centrefy was co-founded by Nati Nachmany.
What is the name of Centrefy's core product?
Centrefy's core product is Victor, a proactive health companion designed to monitor patient progress and predict treatment outcomes.
When was Centrefy founded?
Centrefy was founded in October 2019.
What is Centrefy's current operational status?
Centrefy is currently non-active and ceased to operate in December 2025.
Log in to access full profile